✨ Free AI Report
Vetoquinol SA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Vetoquinol SA
Company Research

Vetoquinol SA: Business Overview, Financials & Competitive Analysis

Vetoquinol is a France-based veterinary pharmaceutical company founded in 1933 that designs, develops, and sells veterinary drugs and non-medicinal products for livestock and companion animals across 100+ countries. T...

Analyst-debate audio for Vetoquinol SA

AskCyborg analysts argue the bull and bear cases for Vetoquinol SA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Vetoquinol offers stable cash generation in the defensive veterinary pharma sector with geographic diversification, but faces...

Read the full analyst-debate transcript →
Industry Veterinary Pharmaceuticals
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Vetoquinol SA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Vetoquinol SA Overview

Pro stress-test →

Vetoquinol is a France-based veterinary pharmaceutical company founded in 1933 that designs, develops, and sells veterinary drugs and non-medicinal products for livestock and companion animals across 100+ countries. The company reported €526 million in annual sales for 2025, with 70% from companion animals (dogs, cats) and 30% from livestock (cattle, pigs).

Strategic Profile

Pro stress-test →

Vetoquinol operates as a diversified player in the global veterinary pharma market with products spanning pain/inflammation, antibiotics, anti-parasites, dermatology, cardiology, and behavior management. The company's geographic diversification—Europe 48.9%, North America 35.7%, Asia-Pacific 15.4%—and portfolio spanning 5 production sites globally provides operational resilience and market penetration advantages.

Competitive Landscape

Pro stress-test →

Vetoquinol competes in the global veterinary pharmaceuticals market alongside larger players like Zoetis (dominant global competitor) and regional competitors. The market is characterized by consolidation, with Vetoquinol maintaining mid-market positioning through specialized therapeutic portfolios and geographic reach.

Industry Context

Vetoquinol SA operates in Veterinary Pharmaceuticals.

Key facts

Founded: 1933 · Headquarters: Lure, France · Employees: ~2,000 · Revenue: €526M (2025) · Market cap: €922M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Vetoquinol SA.

  • Pet products represent 70% of sales—capturing tailwinds in premium pet healthcare spending and humanization of pet care
  • Essential Products segment grew 4.1% at constant exchange rates in 2025, demonstrating product portfolio resilience
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Monthly voting rights disclosure and buyback program announcements
  • February 20262025 annual results released with €526M revenue
  • +1 moreTrack every material event for Vetoquinol SA as it happens. Explore monitoring →
Get alerted when Vetoquinol SA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Animal health divisionGlobal veterinary pharma leader and primary competitor→Veterinary pharmaceuticalsMajor animal health division competitor→Companion animal productsSignificant player in pet and livestock segments→

Compare Vetoquinol SA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Vetoquinol SA operates in Veterinary Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Veterinary Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Vetoquinol SA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Vetoquinol SA and its top competitor on Cyborg Score”
“What did Vetoquinol SA do this quarter?”
“Is Vetoquinol SA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Vetoquinol SA do?+
Vetoquinol is a France-based veterinary pharmaceutical company founded in 1933 that designs, develops, and sells veterinary drugs and non-medicinal products for livestock and companion animals across 100+ countries. T...
What is Vetoquinol SA's Cyborg Score?+
Vetoquinol SA has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Vetoquinol SA's main competitors?+
Named competitors include Animal health division, Veterinary pharmaceuticals, Companion animal products. The full competitive landscape is in the AskCyborg report.
How can I get the full Vetoquinol SA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Vetoquinol SA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Vetoquinol SA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.